IBOGAINE
THAILAND

Microdosing uses doses that remain well below the threshold associated with the full ibogaine experience. Most individuals report subtle shifts in mood, clarity, or emotional regulation rather than visionary effects. The intention of microdosing is gradual support rather than an immersive psychoactive experience.

Protocols vary depending on the individual. Some programs may run for several weeks, while others involve spaced intervals over longer integration periods. The structure depends on medical considerations, treatment history, and personal goals.

Some individuals explore microdosing as part of a broader recovery and integration process. When combined with therapy, lifestyle change, and integration work, it may support the stabilisation of healthier behavioural patterns. Microdosing should not be viewed as a standalone treatment.

Ibogaine affects both neurological and cardiovascular systems. Because of this, microdosing should never be undertaken without proper screening and professional supervision. Medical history, medications, and cardiac health must always be evaluated beforehand.

Microdosing in this context involves the use of very small, controlled amounts of ibogaine or iboga alkaloids over a defined period. These doses are designed to remain below the threshold of the full ibogaine experience, allowing individuals to continue with daily life while engaging in a gradual and monitored process. Preclinical research has associated ibogaine with increased expression of glial cell line-derived neurotrophic factor (GDNF), a protein involved in the survival and support of dopamine-producing neurons. GDNF has been a long-standing focus in research into neurodegenerative conditions such as Parkinson’s disease, due to its potential role in supporting damaged dopaminergic pathways. Ibogaine and its metabolite, noribogaine, also interact with multiple neurological systems involved in mood, reward processing, and neuroplasticity. While these mechanisms are still being studied, they help explain why some individuals are drawn to a more gradual and medically supervised approach. Observed Outcomes In our experience, some individuals have reported changes in: mobility and coordination muscular control emotional regulation overall functional capacity These responses vary significantly between individuals, and no specific outcome can be assumed.This approach remains exploratory, and expectations should be grounded and realistic. Individuals interested in this program are invited to begin with a confidential consultation.This allows us to assess medical suitability, understand your context, and determine whether this approach may be appropriate.

No. Microdosing and full ibogaine treatment serve different purposes. Full sessions are typically used for deep psychological work and pattern interruption. Microdosing tends to support gradual stabilisation, reflection, and integration over time.

All microdosing protocols at Ibogaine Thailand are individually designed. Suitability depends on medical history, medications, psychological background, and treatment goals. Individuals interested in exploring this approach are encouraged to begin with a confidential consultation. Email: info@ibogaine-thailand.net